Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 2/20 | 0.76 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.59 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.59 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.59 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.59 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.59 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.59 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.59 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.59 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.59 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.59 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | DRD2 | P14416 | 1/20 | 0.54 |
| ▸ | DRD4 | P21917 | 1/20 | 0.54 |
| ▸ | DRD3 | P35462 | 1/20 | 0.54 |
| ▸ | LTA4H | P09960 | 2/20 | 0.53 |
| ▸ | HTR1B | P28222 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8498812 | 0.98 | KCNA3 (0.73) | KCNA3HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL8501351 | 0.98 | KCNA3 (0.73) | KCNA3HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL8498126 | 0.98 | KCNA3 (0.73) | KCNA3HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL8496084 | 0.98 | KCNA3 (0.73) | KCNA3HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL5575867 | 0.98 | KCNA3 (0.73) | KCNA3HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL8495999 | 0.98 | KCNA3 (0.73) | KCNA3HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL8499690 | 0.98 | KCNA3 (0.73) | KCNA3HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL8501296 | 0.98 | KCNA3 (0.73) | KCNA3HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL94687 | 0.98 | KCNA3 (0.73) | KCNA3HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL6238396 | 0.98 | KCNA3 (0.73) | KCNA3HDAC3HDAC4HDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 438 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11952450-B2 | Compound for encapsulation film and composition thereof, and film, organic light-emitting device and encapsulation method | JILIN OLED OPTICAL AND ELECTRONIC MATERIALS CO., LTD. (CN) | 2024-04-09 | — | — | US | claimed |
| CN-115521230-A | Silicon-containing monomer, photocuring composition, packaging film and organic electroluminescent device comprising packaging film | 吉林奥来德光电材料股份有限公司 | 2022-12-27 | — | — | CN | claimed |
| CN-114957314-A | Compound for film packaging, composition, packaging film and film packaging structure | 吉林奥来德光电材料股份有限公司 | 2022-08-30 | — | — | CN | claimed |
| US-20220259352-A1 | Compound for encapsulation film and composition thereof, and film, organic light-emitting device and encapsulation method | JILIN OLED OPTICAL AND ELECTRONIC MATERIALS CO., LTD. (CN) | 2022-08-18 | — | — | US | claimed |
| US-20120196995-A1 | PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2012-08-02 | — | — | US | claimed |
| CN-100513397-C | Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors | MEMORY PHARM CORP (US) | 2009-07-15 | — | — | CN | claimed |
| US-20060205938-A1 | Monohydrate solvates of loracarbef | RANBAXY LABORATORIES LIMITED (IN) | 2006-09-14 | — | — | US | claimed |
| CN-1714081-A | Phosphodiesterase 4 inhibitors | MEMORY PHARM CORP (US) | 2005-12-28 | — | — | CN | claimed |
| EP-1565462-A1 | MONOHYDRATE SOLVATES OF LORACARBEF | RANBAXY LABORATORIES, LTD. (IN) | 2005-08-24 | — | — | EP | claimed |
| WO-2004046142-A1 | MONOHYDRATE SOLVATES OF LORACARBEF | RANBAXY LABORATORIES LIMITED (IN) | 2004-06-03 | — | — | WO | claimed |
| US-6075147-A | OMEGA-PHENYL-OMEGA-(3-PYRIDYL)-OMEGA-ALKENOIC ACID DERIVATIVES BEARING A CARBAMOYL SUBSTITUTED OXAZOLYL OR OXAZOLINYL GROUP ON THE PHENYL RING IS USEFUL FOR THROMBOXANE RECEPTOR ANTAGONSIM OR THROMBOXANE SYNTHASE INHIBITOR | ELI LILLY AND COMPANY (US) | 2000-06-13 | — | — | US | claimed |
| US-6031095-A | Intermediates in the preparation of substituted alkenoic acids | ELI LILLY AND COMPANY (US) | 2000-02-29 | — | — | US | claimed |
| US-5990308-A | Intermediates in the preparation of substituted alkenoic acids | ELI LILLY AND COMPANY (US) | 1999-11-23 | — | — | US | claimed |
| EP-0920414-A1 | MATRIX METALLOPROTEINASE INHIBITORS | PHARMACIA & UPJOHN S.p.A. (IT) | 1999-06-09 | — | — | EP | claimed |
| US-5849922-A | Preparation of substituted alkenoic acids | ELI LILLY AND COMPANY (US) | 1998-12-15 | — | — | US | claimed |
| US-5849766-A | Carbamoyl substituted heterocycles | ELI LILLY AND COMPANY (US) | 1998-12-15 | — | — | US | claimed |
| EP-0816361-A2 | Preparation of substituted alkenoic acids | ELI LILLY AND COMPANY (US) | 1998-01-07 | — | — | EP | claimed |
| WO-1997049674-A1 | MATRIX METALLOPROTEINASE INHIBITORS | PHARMACIA & UPJOHN S.P.A. (IT) | 1997-12-31 | — | — | WO | claimed |
| EP-0811621-A2 | Carbamoyl substituted oxazoles as thromboxane receptor antagonists | ELI LILLY AND COMPANY (US) | 1997-12-10 | — | — | EP | claimed |
| EP-0202294-B1 | SYNERGISTIC HERBICIDAL COMPOSITIONS | INNOFINANCE Altalános Innovácios Pénzintézet (HU) | 1989-11-08 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220259352-A1 | Compound for encapsulation film and composition thereof, and film, organic light-emitting device and encapsulation method | AOX1, LOXL1, SEM1 | KCNA3 3765/4885HDAC3 4782/4885HDAC4 4569/4885 |
| US-11952450-B2 | Compound for encapsulation film and composition thereof, and film, organic light-emitting device and encapsulation method | TTPA, LOX, AOX1 | KCNA3 3767/4885HDAC3 4835/4885HDAC4 4642/4885 |
| US-20060205938-A1 | Monohydrate solvates of loracarbef | SLC10A1, DCXR, KLK13 | KCNA3 86/4885HDAC3 629/4885HDAC4 1128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.